← FDA Drug Approvals (Drugs@FDA)

PREGABALIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: STRIDES PHARMA · Approved 2024-01-24

Drug application

FDA Application #

ANDA209883

Application type

Abbreviated New Drug Application (Generic)

Brand name

PREGABALIN

Generic name

Pregabalin

Active ingredients

PREGABALIN

Dosage form

CAPSULE

Route

ORAL

Marketing status

Discontinued

Sponsor

STRIDES PHARMA

First approval

2024-01-24

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown